Effect of dabrafenib on melanoma cell lines harbouring the BRAFV600D/R mutations
BMC CANCER (2013)
期刊
BMC CANCER
卷 13, 期 -, 页码 -出版社
BIOMED CENTRAL LTD
关键词
类别
资金
- Fondazione Melanoma Onlus
作者
我是这篇论文的作者
推荐
Comparative analysis of adjuvant therapy for stage III BRAF-mut melanoma: A real-world retrospective study from single center in China
Jingqin Zhong, Wei Sun, Tu Hu, Chunmeng Wang, Wangjun Yan, Zhiguo Luo, Xin Liu, Yu Xu, Yong Chen
CANCER MEDICINE (2023)
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus
Victoria Atkinson, Caroline Robert, Jean J. Grob, Helen Gogas, Caroline Dutriaux, Lev Demidov, Avinash Gupta, Alexander M. Menzies, Bettina Ryll, Flora Miranda, Hiya Banerjee, Mike Lau, Michele Del Vecchio
EUROPEAN JOURNAL OF CANCER (2022)
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
Ernesto Rossi, Giovanni Schinzari, Francesco Cellini, Mario Balducci, Mariangela Pasqualoni, Brigida Anna Maiorano, Bruno Fionda, Silvia Longo, Francesco Deodato, Alessandro Di Stefani, Ketty Peris, Maria Antonietta Gambacorta, Giampaolo Tortora
BIOMEDICINES (2023)
BRAF inhibition and the spectrum of granulomatous reactions
James P. Pham, Phoebe Star, Kevin Phan, Yanni Loh, Anthony M. Joshua, Annika Smith
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
BRAF L485-P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
Simeng Zhang, Zichang Yang, Yu Cheng, Xiaoyu Guo, Chang Liu, Shuo Wang, Lingyun Zhang
FRONTIERS IN PHARMACOLOGY (2023)
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence
Pawel Rogala, Anna M. Czarnecka, Bozena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko, Marcin Zietek, Robert Dziura, Ewa Rutkowska, Lukasz Galus, Natasza Kempa-Kaminska, Jacek Calik, Agata Salek-Zan, Tomasz Zemelka, Wieslaw Bal, Agnieszka Kamycka, Tomasz Switaj, Grazyna Kaminska-Winciorek, Rafal Suwinski, Jacek Mackiewicz, Piotr Rutkowski
JOURNAL OF CLINICAL MEDICINE (2022)
Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma
Marcos Mozo Cuadrado, Laura Tabuenca Del Barrio, Esther Compains Silva
OCULAR IMMUNOLOGY AND INFLAMMATION (2021)
Phase I-II Open-Label Multicenter Study of Palbociclib plus Vemurafenib in BRAFV600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism
Baptiste Louveau, Matthieu Resche-Rigon, Thierry Lesimple, Laetitia Da Meda, Marc Pracht, Barouyr Baroudjian, Julie Delyon, Mona Amini-Adle, Caroline Dutriaux, Coralie Reger de Moura, Aurelie Sadoux, Fanelie Jouenne, Zineb Ghrieb, Paul Vilquin, Didier Bouton, Annick Tibi, Samuel Huguet, Keyvan Rezai, Maxime Battistella, Samia Mourah, Celeste Lebbe
CLINICAL CANCER RESEARCH (2021)
Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma
Nakul Dar, Sarah E. Gradecki, Elizabeth M. Gaughan
FRONTIERS IN ONCOLOGY (2023)
BH3 mimetics potentiate pro-apoptotic activity of encorafenib in BRAFV600E melanoma cells
Mariusz L. Hartman, Anna Gajos-Michniewicz, Julita A. Talaj, Aleksandra Mielczarek-Lewandowska, Malgorzata Czyz
CANCER LETTERS (2021)
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st-line BRAF-targeted therapy
James Jones, Rebecca Lucey, Pippa Corrie
PIGMENT CELL & MELANOMA RESEARCH (2022)
Quantifying ERK activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modelling
Sara J. Hamis, Yury Kapelyukh, Aileen McLaren, Colin J. Henderson, C. Roland Wolf, Mark A. J. Chaplain
BRITISH JOURNAL OF CANCER (2021)
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study
Martin Salzmann, Alexander Wald, Henner Stege, Carmen Loquai, Lisa Zimmer, Kinan M. Hayani, Lucie Heinzerling, Ralf Gutzmer, Alexander H. Enk, Jessica C. Hassel
CANCERS (2023)
High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens
Lauren Y. Cheng, Lauren E. Haydu, Ping Song, Jianyi Nie, Michael T. Tetzlaff, Lawrence N. Kwong, Jeffrey E. Gershenwald, Michael A. Davies, David Yu Zhang
SCIENTIFIC REPORTS (2021)
5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF(V600) Mutation-Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study
Paolo A. Ascierto, Brigitte Dreno, James Larkin, Antoni Ribas, Gabriella Liszkay, Michele Maio, Mario Mandala, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas, Luis de la Cruz-Merino, Victoria Atkinson, Caroline Dutriaux, Claus Garbe, Jessie Hsu, Surai Jones, Haocheng Li, Edward McKenna, Athina Voulgari, Grant A. McArthur
CLINICAL CANCER RESEARCH (2021)
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
Paolo A. A. Ascierto, Mario Mandala, Pier Francesso Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Virginia Ferraresi, Ana Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbe, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F. F. Sanmamed, Domenico Mallardo, Marcello Curvietto, Ignacio Melero, Giuseppe Palmieri, Antonio M. Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni
JOURNAL OF CLINICAL ONCOLOGY (2023)
CD14+/CD31+monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII
Muhammad Elnaggar, Anjud Al-Mohannadi, Waseem Hasan, Doua Abdelrahman, Mohammed J. Al-Kubaisi, Igor Pavlovski, Giusy Gentilcore, Abbirami Sathappan, Dhanya Kizhakayil, Aesha I. Ali, Suruchi Mohan, Damilola Olagunju, Chiara Cugno, Jean-Charles Grivel, Chiara Borsotti, Antonia Follenzi, Sahar I. Da'as, Sara Deola
BLOOD ADVANCES (2023)
Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group
Daniela Massi, Anna Szumera-Cieckiewicz, Llucia Alos, Sara Simi, Filippo Ugolini, Giuseppe Palmieri, Ignazio Stanganelli, Martin G. Cook, Mario Mandala
EUROPEAN JOURNAL OF CANCER (2023)
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition
Robert Ferguson, Vylyny Chat, Leah Morales, Danny Smpson, Kelsey R. Monson, Elisheva Cohen, Sarah Zusin, Gabriele Madonna, Mariaelena Capone, Ester Simeone, Anna Pavlick, Jason J. Luke, Thomas F. Gajewski, Iman Osman, Paolo Ascierto, Jeffrey Weber, Tomas Kirchhoff
EUROPEAN JOURNAL OF CANCER (2023)
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma
Milena Casula, Marina Pisano, Panagiotis Paliogiannis, Maria Colombino, Maria Cristina Sini, Angelo Zinellu, Davide Santeufemia, Antonella Manca, Stefania Casula, Silvia Tore, Renato Lobrano, Antonio Cossu, Giuseppe Palmieri
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors
Mario Mandala, Giuseppe Palmieri, Vienna Ludovini, Sara Baglivo, Francesca Marasciulo, Francesca Castiglione, Alessio Gili, Simona Osella Abate, Marco Rubatto, Rebecca Senetta, Gianluca Avallone, Simone Ribero, Luca Romano, Nicola Pimpinelli, Vincenzo de Giorgi, Fausto Roila, Marina Pisano, Milena Casula, Antonella Manca, Maria Cristina Sini, Daniela Massi, Pietro Quaglino
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonio Pinto, Chrystal M. Paulos, Paolo A. Ascierto
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
Domenico Mallardo, Ester Simeone, Lucia Festino, Marilena Tuffanelli, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mariaelena Capone, Gabriele Madonna, Francesca Sparano, Eleonora Cioli, Luigi Scarpato, Marco Palla, Rossella Di Trolio, Paolo Meinardi, Corrado Caraco, Gerardo Ferrara, Paolo Muto, Ernesta Cavalcanti, Paolo Antonio Ascierto
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases
Daniele Armocida, Alessandro Pesce, Mauro Palmieri, Fabio Cofano, Giuseppe Palmieri, Paola Cassoni, Carla Letizia Busceti, Francesca Biagioni, Diego Garbossa, Francesco Fornai, Antonio Santoro, Alessandro Frati
JOURNAL OF CLINICAL MEDICINE (2023)
Current Trends in Mucosal Melanomas: An Overview
Davide Adriano Santeufemia, Giuseppe Palmieri, Gianmaria Miolo, Maria Colombino, Maria Grazia Doro, Laura Frogheri, Panagiotis Paliogiannis, Giampiero Capobianco, Massimo Madonia, Giovanni Lo Re, Antonio Cossu, Giuseppe Corona
CANCERS (2023)
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
Nicolas Gonzalo Nunez, Fiamma Berner, Ekaterina Friebel, Susanne Unger, Nina Wyss, Julia Martinez Gomez, Mette-Triin Purde, Rebekka Niederer, Maximilian Porsch, Christa Lichtensteiger, Rafaela Kramer, Michael Erdmann, Christina Schmitt, Lucie Heinzerling, Marie-Therese Abdou, Julia Karbach, Dirk Schadendorf, Lisa Zimmer, Selma Ugurel, Niklas Kluemper, Michael Hoelzel, Laura Power, Stefanie Kreutmair, Mariaelena Capone, Gabriele Madonna, Lacin Cevhertas, Anja Heider, Teresa Amaral, Omar Hasan Ali, David Bomze, Florentia Dimitriou, Stefan Diem, Paolo Antonio Ascierto, Reinhard Dummer, Elke Jaeger, Christoph Driessen, Mitchell Paul Levesque, Willem van de Veen, Markus Joerger, Martin Frueh, Burkhard Becher, Lukas Flatz
MED (2023)
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps
Luca Modestino, Leonardo Cristinziano, Marialuisa Trocchia, Annagioia Ventrici, Mariaelena Capone, Gabriele Madonna, Stefania Loffredo, Anne Lise Ferrara, Marilena Romanelli, Ester Simeone, Gilda Varricchi, Francesca Wanda Rossi, Amato de Paulis, Gianni Marone, Paolo Antonio Ascierto, Maria Rosaria Galdiero
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
Nicia I. Profili, Roberto Castelli, Antonio Gidaro, Alessandro Merella, Roberto Manetti, Giuseppe Palmieri, Margherita Maioli, Alessandro P. Delitala
JOURNAL OF CLINICAL MEDICINE (2023)
PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis
Renato Lobrano, Panagiotis Paliogiannis, Angelo Zinellu, Giuseppe Palmieri, Ivana Persico, Arduino A. A. Mangoni, Antonio Cossu
CURRENT ONCOLOGY (2023)
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer
Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone, Silvia Sale, Carmine Nicastro, Lidia Atripaldi, Giuseppe Fiorentino, Roberto Parrella, Vincenzo Montesarchio, Luigi Atripaldi, Paolo A. Ascierto, Alfredo Budillon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)